PH26229A - Azithromycin and derivatives as antiprotozoal agents - Google Patents

Azithromycin and derivatives as antiprotozoal agents Download PDF

Info

Publication number
PH26229A
PH26229A PH37527A PH37527A PH26229A PH 26229 A PH26229 A PH 26229A PH 37527 A PH37527 A PH 37527A PH 37527 A PH37527 A PH 37527A PH 26229 A PH26229 A PH 26229A
Authority
PH
Philippines
Prior art keywords
azithromycin
deoxy
epi
amino
comprises administering
Prior art date
Application number
PH37527A
Other languages
English (en)
Inventor
Jack Samuel Remington
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH26229A publication Critical patent/PH26229A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH37527A 1987-09-10 1988-09-09 Azithromycin and derivatives as antiprotozoal agents PH26229A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/002317 WO1989002271A1 (en) 1987-09-10 1987-09-10 Azithromycin and derivatives as antiprotozoal agents

Publications (1)

Publication Number Publication Date
PH26229A true PH26229A (en) 1992-04-01

Family

ID=22202554

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37527A PH26229A (en) 1987-09-10 1988-09-09 Azithromycin and derivatives as antiprotozoal agents

Country Status (18)

Country Link
US (1) US4963531A (de)
EP (1) EP0307128B1 (de)
JP (1) JPH0667847B2 (de)
KR (1) KR930011996B1 (de)
AT (1) ATE74508T1 (de)
AU (1) AU596029B2 (de)
CA (1) CA1334574C (de)
DE (1) DE3869880D1 (de)
DK (1) DK175544B1 (de)
HU (1) HUT47553A (de)
IE (1) IE61507B1 (de)
IL (1) IL87698A (de)
MY (1) MY103388A (de)
NZ (1) NZ226112A (de)
PH (1) PH26229A (de)
PT (1) PT88448B (de)
WO (1) WO1989002271A1 (de)
ZA (1) ZA886727B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2066324C1 (ru) 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
TW271400B (de) * 1992-07-30 1996-03-01 Pfizer
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
ATE143601T1 (de) * 1993-05-05 1996-10-15 Palo Alto Medical Found Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
CA2189001A1 (en) * 1994-04-26 1995-11-02 Nobuhiro Narita Medicinal composition as a remedy for nonsmall cell lung cancer
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
AU744318B2 (en) * 1994-04-29 2002-02-21 Pfizer Inc. Method of administering azithromycin
NZ283160A (en) * 1994-05-06 1998-07-28 Pfizer Azithromycin in a controlled release dosage form for treating microbiol infections
US20030212123A1 (en) * 1997-05-05 2003-11-13 Pfizer Inc. COX-2 selective carprofen for treating pain and inflammation in dogs
US6407074B1 (en) * 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
PT1437359E (pt) * 1997-10-16 2007-04-30 Glaxosmithkline Zagreb Novos 3,6-hemicetais da classe dos 9a-azalidos
CZ20011886A3 (cs) * 1998-11-30 2001-10-17 Teva Pharmaceutical Industries Ltd. Etanolát azitromycinu, postup přípravy a jeho farmaceutické preparáty
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
ATE388159T1 (de) * 2000-01-04 2008-03-15 Teva Pharma Verfahren zur herstellung von azithromycin- dihydrat
WO2002007736A1 (en) * 2000-07-24 2002-01-31 Cadila Pharmaceuticals Limited The process for manufacturing of clear liquid pharmaceutical composition of azithromycin
ATE320441T1 (de) 2000-07-25 2006-04-15 Silanes Sa De Cv Lab Einstufiges verfahren zur herstellung von 7,16-
WO2002009640A2 (en) * 2000-08-01 2002-02-07 Shiva Prasad Singh Process for the preparation of anhydrous azithromycin
DE60114028T2 (de) * 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
CZ303343B6 (cs) * 2000-11-27 2012-08-08 Sandoz Ag Zpusob prípravy azithromycinu ve forme monohydrátu
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
BR0209918A (pt) * 2001-05-22 2004-03-30 Pfizer Prod Inc Formas cristalinas da azitromicina
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
SI1390377T1 (sl) 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
OA12845A (en) * 2001-08-21 2006-09-15 Pfizer Prod Inc Single dose azithromycin for treating respiratory infections.
EP1446010B1 (de) * 2001-10-18 2009-04-15 Teva Pharmaceutical Industries Ltd. Stabilisierte azithromycin-zusammensetzungen
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
AU2002348884A1 (en) * 2001-12-21 2003-07-09 Pfizer Products Inc. Directly compressible formulations of azithromycin
KR100669279B1 (ko) * 2001-12-21 2007-01-16 화이자 프로덕츠 인크. 아지트로마이신의 습식 제립 방법
RU2212242C1 (ru) * 2001-12-24 2003-09-20 Закрытое акционерное общество "Брынцалов-А" Антибиотик сумазид
MXPA04007427A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formulaciones de azitromicina granuladas por via seca.
ES2220229B1 (es) * 2003-05-29 2005-10-16 Quimica Sintetica, S.A. Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
AU2004294813A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
BRPI0416534A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
EP1691787B1 (de) 2003-12-04 2008-07-02 Pfizer Products Inc. Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547239A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
CA2549225A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
CN1295719C (zh) * 2003-12-30 2007-01-17 郑玉庆 远程智能型变压器
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
CN100427499C (zh) * 2005-12-20 2008-10-22 山东诚创医药技术开发有限公司 一种阿奇霉素的可溶性盐及其制备方法
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
AU8280087A (en) * 1987-09-10 1989-04-17 Pfizer Inc. Azithromycin and derivatives as antiprotozoal agents

Also Published As

Publication number Publication date
KR890004709A (ko) 1989-05-09
MY103388A (en) 1993-06-30
EP0307128A3 (en) 1990-07-04
CA1334574C (en) 1995-02-28
JPH0667847B2 (ja) 1994-08-31
WO1989002271A1 (en) 1989-03-23
DK502888A (da) 1989-03-13
US4963531A (en) 1990-10-16
JPH0283326A (ja) 1990-03-23
KR930011996B1 (ko) 1993-12-23
PT88448A (pt) 1989-07-31
AU596029B2 (en) 1990-04-12
ATE74508T1 (de) 1992-04-15
IE882762L (en) 1989-03-10
HUT47553A (en) 1989-03-28
DK175544B1 (da) 2004-11-29
ZA886727B (en) 1990-04-25
EP0307128B1 (de) 1992-04-08
EP0307128A2 (de) 1989-03-15
IE61507B1 (en) 1994-11-02
DE3869880D1 (de) 1992-05-14
DK502888D0 (da) 1988-09-09
NZ226112A (en) 1997-03-24
AU2206188A (en) 1989-05-11
PT88448B (pt) 1992-10-30
IL87698A (en) 1992-12-01
IL87698A0 (en) 1989-02-28

Similar Documents

Publication Publication Date Title
EP0307128B1 (de) Azithromycin und seine Derivate als Antiprotozoenmittel
US6004951A (en) Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
US5258376A (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
SK282607B6 (sk) Farmaceutický prostriedok obsahujúci uhličitan lantanitý, spôsob prípravy tejto zlúčeniny a jej použitie
JPH026409A (ja) ジホスホン酸誘導体経口医薬組成物
US5574027A (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5182112A (en) Antidiarrheal compositions containing laperamide hydrochloride and a saccharide
EP1318804B1 (de) Eisenverbindungen
US5036103A (en) Method of treating cancer cells in humans
JPH07507288A (ja) デスフェリオキサミン−ｂ塩及び経口的に有効な鉄キレート剤としてのそれらの使用
NL194430C (nl) Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
AU8280087A (en) Azithromycin and derivatives as antiprotozoal agents
EP0612246B1 (de) Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen
EP0476391B1 (de) Anti-AIDS-Zusammensetzung mit Cepharanthin als Wirkstoff
WO1991017751A1 (en) Orally administrable gallium compositions and methods of treatment therewith
WO2021161981A1 (en) Novel medicament for treating hepatic encephalopathy
EP0435693B1 (de) Pharmazeutische Zubereitungen, die 3-Oxygermylpropionsäurepolymere enthalten zur Hemmung von Zelldegeneration
JPH0120128B2 (de)
AU1359492A (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
JPS62263123A (ja) 新規免疫抑制剤
JPS62195329A (ja) アントラサイクリン系抗生物質の副作用軽減剤